Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 30
Filter
1.
Occup Med (Lond) ; 72(2): 110-117, 2022 02 22.
Article in English | MEDLINE | ID: mdl-34919710

ABSTRACT

BACKGROUND: Health care workers (HCWs) are on the frontline, playing a crucial role in the prevention of infection and treatment of patients. AIMS: This study was aimed to evaluate the prevalence of hospital-acquired coronavirus disease 2019 (COVID-19) infection at work and related factors at the University Hospital of Trieste workers exposed to COVID-19 patients. METHODS: From March 1 to May 31, of 4216 employees, 963 were in contact with COVID-19 patients or colleagues and were followed up. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in nasopharyngeal swabs was determined every 3 days, by RT-PCR. RESULTS: During the follow-up period, 193 workers were positive for COVID-19 (5%), and 165 of these (86%) were symptomatic. We identified five major cluster outbreaks of COVID-19 infection in Trieste Hospitals, four of which occurred before the implementation of universal masking for HCWs and patients (1-14 March 2020). COVID-19 infection was significantly higher in high-risk ward workers (Infectious Diseases, and Geriatric and Emergency Medicine, odds ratio [OR] 13.4; 95% confidence interval [CI] 5.8-31), in subjects with symptoms (OR 5.4; 95% CI 2.9-10) and in those with contacts with COVID-19 patients and colleagues (OR 2.23; 95% CI 1.01-4.9). CONCLUSIONS: Hospital workers were commonly infected due to contact with COVID-19 patients and colleagues, mainly in the first 15 days of the pandemic, before the implementation of universal mask wearing of HCWs and patients. Repetitive testing and follow-up permitted the identification of COVID-19 cases before symptom onset, obtaining better infection prevention and control.


Subject(s)
COVID-19 , Aged , Disease Outbreaks , Health Personnel , Hospitals, University , Humans , Personnel, Hospital , SARS-CoV-2
3.
J Prev Med Hyg ; 60(3): E163-E170, 2019 Sep.
Article in English | MEDLINE | ID: mdl-31650049

ABSTRACT

INTRODUCTION: Influenza is a matter of serious concern for clinicians, in both outpatient and in-hospital settings. Worldwide, the 2017-18 epidemic proved to be the most severe since 2003-04. We report a real-world experience regarding the management of patients with influenza admitted to a large teaching hospital in the Friuli Venezia Giulia region during the 2017-2018 influenza season. We also provide a practical guide for the management of hospitalized influenza patients. METHODS: A retrospective observational analysis was conducted among all influenza patients requiring admission to our center during the 2017-18 season. RESULTS: Overall, 29 patients were admitted to the University Hospital of Udine during the 2017-18 season with a diagnosis of influenza. B virus was responsible for the majority of cases. More than 65.5% of the subjects presented with a complication. We estimated that 41.4% of the patients admitted were affected by a "severe form". All these cases required admission to the Intensive Care Unit, with 27.6% and 10.3% needing Orotracheal Intubation and Extracorporeal Membrane Oxygenation, respectively. The fatality rate was 24.1%. Notably, only 9 subjects in our cohort had been vaccinated. Based on the experience acquired during the past season, we propose a practical guide to the management of influenza cases in everyday hospital practice. CONCLUSION: The cornerstones of the management of all hospitalized influenza patients are the rapid identification and treatment of severe forms. Timely and strict adherence to contact and respiratory precautions are also fundamental to reducing the risk of intra-hospital outbreaks. Despite improvements in antiviral therapies and supportive measures, influenza-related morbidity and mortality remain high. In our opinion, a universal vaccination program is the only safe and effective method of filling the gap.


Subject(s)
Antiviral Agents/therapeutic use , Coinfection/therapy , Extracorporeal Membrane Oxygenation , Influenza, Human/therapy , Myocarditis/therapy , Pneumonia, Bacterial/therapy , Respiration, Artificial , Respiratory Distress Syndrome/therapy , Adolescent , Adult , Aged , Aged, 80 and over , Child , Child, Preschool , Early Diagnosis , Early Medical Intervention , Female , Hospitalization , Humans , Infant , Infant, Newborn , Infection Control , Influenza Vaccines/therapeutic use , Influenza, Human/complications , Influenza, Human/prevention & control , Intensive Care Units , Intubation, Intratracheal , Italy , Male , Middle Aged , Patient Isolation , Pneumonia, Bacterial/complications , Respiratory Distress Syndrome/etiology , Retrospective Studies , Severity of Illness Index , Young Adult
4.
Ticks Tick Borne Dis ; 10(4): 935-941, 2019 06.
Article in English | MEDLINE | ID: mdl-31072731

ABSTRACT

Tick-borne encephalitis virus (TBEV) is a member of the Flavivirus genus and is the main pathogenic arbovirus circulating in Europe, Russia and China. The envelope (E) protein is exposed on the viral surface and is the main antigen that is employed in diagnostic tests based on the detection of protein-specific antibodies from serum samples of infected individuals. The high degree of similarity among the E proteins of flaviviruses can, in some cases, lead to cross-reactivity and false-positive results in serological tests. Increased specificity in the detection of positive sera for different Flavivirus infections is often obtained by using a portion of the E protein, namely, the DIII domain. Different strategies and expression systems have been described for E and DIII protein production. Here, we present the optimization of an easy and fast method for TBEV E and DIII antigen production and partial purification from E. coli inclusion bodies. The antigenic properties of the produced antigens are retained, as validated by ELISAs with anti-TBEV murine sera as well as sera from infected human patients. The potential applications of both proteins as diagnostic reagents were confirmed.


Subject(s)
Antigens, Viral/immunology , Encephalitis Viruses, Tick-Borne/immunology , Escherichia coli/genetics , Recombinant Proteins/biosynthesis , Viral Envelope Proteins/immunology , Animals , Antibodies, Viral/blood , Antigens, Viral/biosynthesis , Antigens, Viral/genetics , Cloning, Molecular , Encephalitis, Tick-Borne/diagnosis , Encephalitis, Tick-Borne/immunology , Enzyme-Linked Immunosorbent Assay , Flavivirus Infections/diagnosis , Flavivirus Infections/immunology , Humans , Mice , Mice, Inbred BALB C , Recombinant Proteins/genetics , Recombinant Proteins/immunology , Viral Envelope Proteins/biosynthesis , Viral Envelope Proteins/genetics
5.
J Neurovirol ; 22(6): 861-865, 2016 12.
Article in English | MEDLINE | ID: mdl-27245591

ABSTRACT

A 21-year-old woman presented with acute-onset spastic paraparesis. The MRI spinal scan revealed a contrast-enhanced T2 hyperintensity between C5-T2. The most common neurotropic pathogens were excluded by first level tests. Under suspicion of an acute immune-mediated myelitis, a corticosteroid therapy was administered. However, a seropositivity for both human immunodeficiency virus (HIV) type 1 and human T-lymphotropic virus (HTLV) subsequently emerged. An antiretroviral therapy was started while steroids discontinued. Patient's clinical conditions remained unchanged. HIV-HTLV-1 co-infection should be included in the differential diagnosis of any acute myelitis, even in patients with a preserved immune status and no risk factors.


Subject(s)
HIV Infections/diagnosis , HIV/pathogenicity , HTLV-I Infections/diagnosis , Human T-lymphotropic virus 1/pathogenicity , Paraparesis, Tropical Spastic/diagnosis , Antibodies, Viral/blood , Antibodies, Viral/cerebrospinal fluid , Antiviral Agents/therapeutic use , Coinfection , Diagnosis, Differential , Female , HIV Infections/drug therapy , HIV Infections/pathology , HIV Infections/virology , HTLV-I Infections/drug therapy , HTLV-I Infections/pathology , HTLV-I Infections/virology , Humans , Magnetic Resonance Imaging , Paraparesis, Tropical Spastic/drug therapy , Paraparesis, Tropical Spastic/pathology , Paraparesis, Tropical Spastic/virology , Young Adult
7.
Epidemiol Infect ; 139(11): 1727-33, 2011 Nov.
Article in English | MEDLINE | ID: mdl-21396148

ABSTRACT

Two distinct measles outbreaks, unrelated from the epidemiological point of view but caused by genetically related strains, occurred in the Friuli Venezia Giulia region of northeastern Italy. Forty-two cases were reported during the period April-May 2008. In the first outbreak the index case was a teacher who introduced the virus into the Pordenone area, involving eight adolescents and young adults. The other concomitant outbreak occurred in the city of Trieste with 33 cases. The containment of the epidemics can be explained by the high MMR vaccine coverage in an area where the first dose was delivered to 93·4% and the second dose to 88·3% of the target children. Phylogenetic analysis of 14 measles virus strains showed that they belonged to a unique D4 genotype indistinguishable from the MVs/Enfield.GBR/14.07 strain, probably introduced from areas (i.e. Piedmont and Germany) where this genotype was present or had recently caused a large epidemic.


Subject(s)
Community-Acquired Infections/epidemiology , Disease Outbreaks/statistics & numerical data , Measles Vaccine/administration & dosage , Measles virus/isolation & purification , Measles/epidemiology , Adolescent , Adult , Chi-Square Distribution , Child , Child, Preschool , Community-Acquired Infections/immunology , Community-Acquired Infections/prevention & control , Community-Acquired Infections/virology , Female , Humans , Immunization Schedule , Infant , Italy/epidemiology , Male , Measles/immunology , Measles/prevention & control , Measles/virology , Measles Vaccine/immunology , Measles virus/genetics , Measles virus/immunology , Middle Aged , Molecular Epidemiology , Phylogeny
8.
Med Vet Entomol ; 24(3): 220-6, 2010 Sep.
Article in English | MEDLINE | ID: mdl-20534008

ABSTRACT

A 2-year study was conducted in a mountainous area of northeast Italy to evaluate the occurrence and distribution of ticks, as well as to assess the prevalence of the spirochaete Borrelia burgdorferi sensu lato. All ticks collected were Ixodes ricinus L. (Parasitiformes: Ixodidae). In general, most nymphs and adult ticks were collected from April to July. Tick density was highly variable among sites; however, two areas with different infestation levels were recognized. Prevalences of B. burgdorferi s.l. in nymphal stages were rather variable between sites; overall the prevalence of infected nymphs in the whole area was slightly higher than 20%. The prevalence of B. burgdorferi s.l. in nymphs does not seem to be correlated with nymph density. The correlation between the incidence of Lyme borreliosis (reported human cases/1000 inhabitants/year) and Borrelia prevalence in nymphs was not significant, although a significant correlation was found between borreliosis incidence and nymph density.


Subject(s)
Lyme Disease/epidemiology , Ticks , Animals , Borrelia burgdorferi , Climate , Ecology , Humans , Incidence , Italy/epidemiology , Ixodes/microbiology , Lyme Disease/parasitology , Nymph , Population Density , Prevalence , Seasons , Ticks/microbiology
9.
J Med Virol ; 81(2): 309-16, 2009 Feb.
Article in English | MEDLINE | ID: mdl-19107965

ABSTRACT

In Alpine area of extreme North Eastern Italy the first autochthonous case of TBE was reported in 1998 and was followed by 45 cases during the period 2001-2007, thus defining this area as definitely endemic. An ecological survey evaluated the tick density and the Tick-borne encephalitis virus (TBEV) infection prevalence in tick collected in selected sites. In addition, TBE strains were characterized by sequencing and phylogenetic analysis. Overall, 2,361 ticks (2,198 nymphs and 163 adults) of the Ixodes ricinus L. species collected during 2005 and 2006 were examined. Five samples were positive for TBEV, corresponding to an overall prevalence rate of 0.21%. When analyzed by place, TBEV was discovered in three sites where the highest tick density was found. The difference of prevalence between high and low density areas tested to be statistically significant (P = 0.028). Phylogenetic analysis showed that four sequences clustered with the Neudoerfl prototype, while the other clustered with the Isosaari 17 strain and with a number of Slovenian isolates. In addition, a sequence detected in archival samples from one human case segregated with another variant, namely the Swedish Torö strain.


Subject(s)
Encephalitis Viruses, Tick-Borne/physiology , Ixodes/virology , Animals , Base Sequence , Encephalitis Viruses, Tick-Borne/classification , Encephalitis Viruses, Tick-Borne/genetics , Encephalitis Viruses, Tick-Borne/isolation & purification , Italy/epidemiology , Molecular Sequence Data , Phylogeny , Prevalence , RNA, Viral/analysis , RNA, Viral/genetics , Sequence Alignment
10.
J Clin Pathol ; 62(1): 80-3, 2009 Jan.
Article in English | MEDLINE | ID: mdl-18818265

ABSTRACT

OBJECTIVE: To explore the possible role of human herpes virus 6 (HHV-6) in cardiac disorders in childhood in a retrospective study on archival specimens of explanted hearts. METHODS: 16 children (median age at transplantation 11.0 years) with idiopathic dilated cardiomyopathy (DCM) and 19 children (median age at transplantation 1.0 year) with congenital heart disease (CHD), previously found to be negative for other cardiotropic viruses such as enteroviruses, adenovirus, parvovirus B19, cytomegalovirus and Epstein-Barr virus, were tested for HHV-6 by quantitative real-time PCR and by genotyping. In addition, HHV-7/8 infection was investigated by qualitative PCR. RESULTS: HHV-6 B variant was detected in 11 of 35 samples (31.4%) with a mean viral load of 3.1 x 102 copies/microg of DNA. When assessed by heart disorder, the prevalence was different in the two groups (43.7% in DCM and 21% in CHD) while the mean viral loads were similar. In a logistic multivariate analysis HHV-6 was independently associated with DCM, taking CHD as reference and adjusting for age (best estimate: OR = 6.94; 95% CI 1.00 to 49.85; p = 0.05). CONCLUSIONS: Although the clinical significance of the results is unknown, HHV-6 B genome is frequently detected in explanted hearts from children with DCM and to a lesser extent with CHD, thus adding evidence for HHV-6 cardiac involvement.


Subject(s)
Cardiomyopathy, Dilated/virology , Heart Defects, Congenital/virology , Herpesvirus 6, Human/isolation & purification , Roseolovirus Infections/complications , Adolescent , Child , Child, Preschool , Heart/virology , Humans , Infant , Retrospective Studies , Tissue Banks , Viral Load
11.
J Clin Pathol ; 61(3): 355-60, 2008 Mar.
Article in English | MEDLINE | ID: mdl-17630401

ABSTRACT

AIMS: To analyse the epidemiological and molecular features of a long-lasting epidemic (12 weeks) of influenza in north-eastern Italy during the 2004-05 season. METHODS: Morbidity rates were analysed by time and age. Influenza virus isolates (93 strains) were submitted to antigenic evaluation by haemagglutination inhibition test and to molecular assessment by sequencing. RESULTS: The incidence peak (16.4 per thousand) was the highest recorded over the last six years in north-eastern Italy. The epidemic was sustained by two subsequent waves of circulating viruses: an H3N2 variant and two type B variants, respectively. In addition, scattered isolation of an H1N1 variant occurred. Antigenic and molecular characterisation showed the emergence of an H3N2 virus drifted with respect to vaccine strain, which also had a substantial impact on morbidity in vaccinated subjects. Moreover, a single K145N substitution in the HA1 site of H3N2 was the starting point of two evolutionary branches. No change was observed in H1N1 isolates. B-type virus was mainly represented by Victoria-lineage strains, though Yamagata-lineage viruses were also identified. The fluctuating circulation of these two clades has characterised B virus epidemics in recent years. CONCLUSIONS: The assessment of the H3N2 molecular change in this area was in line with results used for establishing the vaccine composition for the incoming season. The particular epidemiological features of two B virus clades, namely Yamagata-like and Victoria-like, may be considered for introduction into the influenza vaccine.


Subject(s)
Developed Countries , Global Health , Influenza, Human/epidemiology , Molecular Epidemiology , Orthomyxoviridae/isolation & purification , Adolescent , Adult , Antigenic Variation , Child , Child, Preschool , Disease Outbreaks , Hemagglutination Inhibition Tests , Hemagglutinin Glycoproteins, Influenza Virus/genetics , Hemagglutinin Glycoproteins, Influenza Virus/immunology , Hemagglutinin Glycoproteins, Influenza Virus/isolation & purification , Humans , Incidence , Influenza A Virus, H1N1 Subtype/genetics , Influenza A Virus, H1N1 Subtype/immunology , Influenza A Virus, H1N1 Subtype/isolation & purification , Influenza A Virus, H3N2 Subtype/genetics , Influenza A Virus, H3N2 Subtype/immunology , Influenza A Virus, H3N2 Subtype/isolation & purification , Influenza, Human/virology , Italy , Middle Aged , Morbidity , Orthomyxoviridae/genetics , Orthomyxoviridae/immunology , Phylogeny , Sequence Analysis, DNA
12.
J Clin Pathol ; 59(5): 526-9, 2006 May.
Article in English | MEDLINE | ID: mdl-16537674

ABSTRACT

OBJECTIVE: To report a retrospective analysis on the presence of hepatitis B virus (HBV), hepatitis C virus (HCV), and transfusion transmitted virus (TTV) sequences in formalin fixed, paraffin embedded liver biopsies from eight patients with hepatocellular carcinoma, in comparison with blood markers. METHODS: A direct in situ polymerase chain reaction (PCR) technique was developed for the detection and localisation of genomic signals in the liver tissue. Conventional serological and molecular methods were used for blood evaluation. RESULTS: In situ PCR showed the presence of one of the three viruses (four HCV, two HBV, and one TTV) in seven of the eight patients. In addition, a co-infection with HBV and HCV was detected in one patient. HCV and HBV sequences were located in the cytoplasm and the nucleus, respectively. When compared with blood markers, these findings were compatible with one occult HBV and two occult HCV infections. CONCLUSIONS: These findings provide further evidence for occult HBV and HCV infections in cancerous tissues from patients with hepatocellular carcinomas. In situ PCR could be an additional tool for evaluating the viral aetiology of hepatocellular carcinoma alongside conventional diagnostic procedures.


Subject(s)
Carcinoma, Hepatocellular/virology , DNA, Viral/analysis , Hepacivirus/genetics , Hepatitis B virus/genetics , Liver Neoplasms/virology , Torque teno virus/genetics , Adult , Antibodies, Viral/blood , Biomarkers/blood , Carcinoma, Hepatocellular/immunology , Female , Hepatitis/virology , Humans , Liver Neoplasms/immunology , Male , Middle Aged , Polymerase Chain Reaction/methods , Retrospective Studies
13.
Ann Ig ; 16(1-2): 109-14, 2004.
Article in Italian | MEDLINE | ID: mdl-15554517

ABSTRACT

To assess the risk of HGV mother-to-infant transmission and the clinical outcome of infected babies, we investigated 103 mother-infant couples and followed-up the infected children for 4-72 months. Twenty (19.4%) mothers were HGV-RNA positive and transmission occurred in ten (50%) babies; only one child acquired HGV and HCV infection. Maternal factors, such as history of intravenous drug use, HCV-RNA positivity, HIV coinfection, type of delivery and type of feeding were not related to HGV transmission. One HGV infected baby showed a mild hepatitis when he was also infected by Cytomegalovirus. Two babies cleared HGV within the first year of life. The HGV transmission rate is elevated but HGV infection seems to be benign, at least in a short-term follow-up.


Subject(s)
Flaviviridae Infections/epidemiology , Flaviviridae Infections/transmission , GB virus C , Hepatitis, Viral, Human/epidemiology , Hepatitis, Viral, Human/transmission , Infectious Disease Transmission, Vertical , Pregnancy Complications, Infectious/epidemiology , Female , Humans , Infant, Newborn , Male , Pregnancy , Pregnancy Outcome , Risk Assessment
14.
Ann Ig ; 16(1-2): 115-21, 2004.
Article in Italian | MEDLINE | ID: mdl-15554518

ABSTRACT

HHV-6 is the etiological agent of Exanthema subitum, and its role in human infection is well known. Recently, molecular diagnostics tools showed for HHV-6 new pathogenetic features and new clinical implication. The present paper highlights recent knowledge on HHV-6 infection and presents a number of results concerning HHV-6 infection in children who had undergone BMT and concerning the roles of endothelial cells as viral reservoir.


Subject(s)
Herpesvirus 6, Human , Roseolovirus Infections , Adult , Child , Herpesvirus 6, Human/physiology , Humans , Roseolovirus Infections/diagnosis , Roseolovirus Infections/epidemiology , Roseolovirus Infections/virology
15.
Eur J Epidemiol ; 19(9): 885-90, 2004.
Article in English | MEDLINE | ID: mdl-15499899

ABSTRACT

The results of the epidemiological and virological surveillance of influenza performed during the 1999/2000, 2000/2001 and 2001/2002 seasons in the northeastern Italy were presented and the relationship between age-specific morbidity rates and circulating strains were discussed.The epidemiological findings pointed out a change in age distribution. During the 1999/2000 season, characterized by a circulation of viruses antigenically close to the vaccine strain, a similar incidence rate in the 0-14 and 15-64-year-old groups was observed, while during the 2001/ 2002 winter the virus infected mostly children. During 2001/2002 season, B type viruses predominated with at least three distinguishable molecular variants. In particular, B/Victoria/2/87-like viruses re-emerged after more than a decade, and the antibodies elicited by the vaccine strain and by the strains circulating in previous seasons were poor or not protecting. The accumulation of susceptible subjects in young age group during the 1990s, due to the lack of circulation of B/Victoria/2/87-like viruses, was responsible for the unusual morbidity in the 0-14 year group. No circulation of B/Victoria/2/87-like viruses was observed in > 64-year-old group during 2001/2002 epidemic, probably due to a long-lasting immunity against viruses belonging to this lineage.


Subject(s)
Influenza B virus/isolation & purification , Influenza, Human/epidemiology , Sentinel Surveillance , Adolescent , Adult , Age Distribution , Aged , Child , Child, Preschool , Disease Outbreaks , Hemagglutination Inhibition Tests , Humans , Incidence , Infant , Influenza B virus/pathogenicity , Influenza, Human/virology , Italy/epidemiology , Middle Aged , Nasal Mucosa/virology
16.
Eur J Epidemiol ; 18(6): 583-8, 2003.
Article in English | MEDLINE | ID: mdl-12908726

ABSTRACT

To assess the prevalence of human T cell leukemia virus type I (HTLV-I) and 2 (HTLV-II) infection and the associated risk factors among immigrants living in Northern Italy, we surveyed 3017 open-population subjects from three geographical areas and 371 prisoners. In the open population, the overall prevalence was 0.3% for HTLV-I and 0.1% for HTLV-II, while among prisoners, HTLV-I and HTLV-II infection were detected in 1.4 and 0.8% of subjects, respectively. HTLV-I prevalence was higher in subjects with multiple sexual partners or sexually transmitted diseases. This association was significant in the open-population group and close to significance in prisoners. Multivariate analysis showed that human immunodeficiency virus (HIV) seropositivity remained significantly associated with HTLV-I infection in both targeted populations (OR: 11.2 in the open population; OR: 9.9 among prisoners), whereas sexual exposure was associated with HTLV-I seropositivity only for prisoners (OR: 14.3). No independent variable was related to HTLV-II infection.


Subject(s)
Emigration and Immigration/statistics & numerical data , HTLV-I Infections/epidemiology , HTLV-II Infections/epidemiology , Adult , Antibodies, Viral/blood , Female , Humans , Italy/epidemiology , Male , Prisoners/statistics & numerical data , Risk Factors , Seroepidemiologic Studies
18.
Haematologica ; 85(11 Suppl): 54-7, 2000 Nov.
Article in English | MEDLINE | ID: mdl-11268325

ABSTRACT

Forty-five consecutive patients submitted to a bone marrow transplant (BMT) were followed up weekly in order to evaluate the incidence of cytomegalovirus (CMV) infections on the basis of CMV antigenemia and polymerase chain reaction. All but one transplanted patients engrafted; fourteen patients out of these were CMV antigenemia positive after 16-184 days (median 32.5, mean 43.4) with an 31.8% incidence. CMV infections were associated with graft-versus-host disease and immunogenetic relationship between the donor and the recipient. No CMV infection was detectable in autologous transplants while antigenemia was demonstrated in 3/11 and 6/7 patients with BMT from respectively mismatched related and matched unrelated donors.


Subject(s)
Bone Marrow Transplantation/adverse effects , Cytomegalovirus Infections/etiology , Adolescent , Adult , Child , Child, Preschool , Female , Humans , Immunosuppression Therapy/adverse effects , Infant , Italy , Male , Transplantation, Autologous , Transplantation, Homologous
19.
Minerva Ginecol ; 52(12 Suppl 1): 92-6, 2000 Dec.
Article in Italian | MEDLINE | ID: mdl-11526696

ABSTRACT

OBJECTIVE: To improve the sensitivity of cervical carcinoma screening and to determine the optimal management with an ASCUS Pap result we evaluated the effectiveness of combining thin layer cytologic slides (ThinPrep) and HPV DNA testing. METHODS: A total of 170 women were studied with conventional Pap smears, liquid based cytology, HPV testing and colposcopy with eventual histologic evaluation. RESULTS: The ThinPrep method yielded 12.5% more high grade lesions than did the conventional smears (and more severe diagnoses as compared to the conventional smears). HPV prevalence was significantly associated with disease status. Of 30 patients with ASCUS, HPV testing detected 100% of high grade lesions and 67% of low grade. If colposcopy had been limited to HPV+ women, 47% of case would have been spared. CONCLUSIONS: Liquid based cell collection improves sensitivity for the detection of disease. For women with ASCUS cytology, HPV DNA testing of residual specimen can identify the majority of high risk cases using a single sample.


Subject(s)
DNA Probes, HPV , Papanicolaou Test , Papillomaviridae/isolation & purification , Vaginal Smears , Cervix Uteri/virology , Female , Humans , Papillomaviridae/classification
20.
J Virol ; 71(3): 2457-62, 1997 Mar.
Article in English | MEDLINE | ID: mdl-9032383

ABSTRACT

We report here that a human immunodeficiency virus type 1 (HIV-1)-specific neutralizing monoclonal antibody (MAb 1575) mapped to the conserved putative intracellular region from amino acid residues 735 to 752 (735-752 region) of gp41 also recognizes a region in an extracellular portion of p17. Both epitopes have a core recognition sequence (IEEE) in a nonhomologous context. The IEEE motif found in HIV-1 p17 is located in a region known as HGP-30 (residues 86 to 115) which has been previously associated with virus neutralization, cytotoxic T lymphocyte activity, and mother-to-child transmission. An analysis of available gp41 and p17 sequences demonstrates that in these regions both IEEE sequences are highly conserved in different HIV-1 clades. The presence of the IEEE epitope in p17 allows us to explain some unexpected neutralizing characteristics of MAb 1575. In addition, the gp41 735-752 region has been previously reported both in intra- and extracellular locations. Our results suggest that the extracellular location was the result of cross-reactivity with p17.


Subject(s)
Epitope Mapping , Epitopes/immunology , HIV Antibodies/immunology , HIV Antigens/immunology , HIV Envelope Protein gp41/immunology , HIV-1/immunology , Peptides/immunology , Antibodies, Monoclonal/immunology , Cell Line , Fluorescent Antibody Technique, Indirect , Genotype , HIV Antigens/genetics , HIV Envelope Protein gp41/genetics , HIV-1/genetics , Humans , Molecular Sequence Data , Neutralization Tests , Peptides/genetics , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/immunology , Tumor Cells, Cultured , gag Gene Products, Human Immunodeficiency Virus
SELECTION OF CITATIONS
SEARCH DETAIL
...